JFL Life Sciences Ltd (JFLLIFE) is currently trading at 10.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

JFL Life Sciences Limited, established in 2010, specializes in the manufacturing and marketing of pharmaceutical products, including dry powder injections and various tablets and capsules. The company has a wide reach with its products distributed across India and exported to 10 countries, including parts of Africa, the Middle East, and CIS nations. JFL Life Sciences has a robust R&D infrastructure and an FDA-approved manufacturing facility near Ahmedabad, enhancing its competitive edge in the pharmaceutical sector. Through its IPO in August 2022, JFL Life Sciences raised approximately Rs. 18.16 Crore, aiding its expansion and financial strategy. The company is strategically registered with health ministries in several countries and uses a stringent quality assurance process for its manufacturing stages.

Over the past 52 weeks, JFL Life Sciences Ltd has traded between a low of ₹10.00 and a high of ₹22.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

JFL Life Sciences Ltd has a market capitalization of approximately 36.13. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

JFL Life Sciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 7.55 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 36.13 Cr, JFL Life Sciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

JFL Life Sciences Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of JFL Life Sciences Ltd is 7.55. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.